Sameera Allie1, Alan Stanley1, Alan Bryer1, Muriel Meiring2, Marc I Combrinck1,3. 1. Division of Neurology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa. 2. Department of Haematology and Cell Biology, University of Free State, Bloemfontein, South Africa. 3. Division of Geriatric Medicine, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Abstract
BACKGROUND: Stroke associated with human immunodeficiency virus infection may occur through a variety of mechanisms. Von Willebrand factor is a marker of endothelial dysfunction, and is elevated in human immunodeficiency virus infection. High levels of von Willebrand factor, a protein involved in platelet adhesion and aggregation, and low levels of ADAMTS13, a metalloproteinase that cleaves von Willebrand factor, have been associated with an increased risk of thrombosis. AIM: To investigate the role of von Willebrand factor and ADAMTS13 in the pathogenesis of human immunodeficiency virus-related stroke in young patients. METHODS: A case-control study (n = 100) comprising three participant groups: human immunodeficiency virus-positive antiretroviral therapy-naïve young strokes (n = 20), human immunodeficiency virus-negative young strokes (n = 40), and human immunodeficiency virus-positive antiretroviral therapy-naïve nonstroke controls (n = 40). von Willebrand factor and ADAMTS13 levels were measured in plasma samples collected five- to seven-days poststroke. RESULTS: Human immunodeficiency virus-positive stroke participants had higher von Willebrand factor levels than human immunodeficiency virus-negative strokes (173·5% vs. 135%, P = 0·032). They tended to have higher levels of von Willebrand factor than human immunodeficiency virus-positive nonstroke controls (173·5% vs. 129%, P = 0·061). Human immunodeficiency virus-positive stroke participants had lower levels of ADAMTS13 than human immunodeficiency virus-positive nonstroke controls (0% vs. 23·5% P = 0·018) most likely due to the effect of the acute stroke. However, in the nonstroke group, these levels were significantly reduced compared with population norms. von Willebrand factor levels in all human immunodeficiency virus-positive participants were negatively correlated with CD4 counts. CONCLUSIONS: Stroke in human immunodeficiency virus infection is associated with a prothrombotic state, characterized by elevated von Willebrand factor and low ADAMTS13 levels.
BACKGROUND:Stroke associated with human immunodeficiency virus infection may occur through a variety of mechanisms. Von Willebrand factor is a marker of endothelial dysfunction, and is elevated in human immunodeficiency virus infection. High levels of von Willebrand factor, a protein involved in platelet adhesion and aggregation, and low levels of ADAMTS13, a metalloproteinase that cleaves von Willebrand factor, have been associated with an increased risk of thrombosis. AIM: To investigate the role of von Willebrand factor and ADAMTS13 in the pathogenesis of human immunodeficiency virus-related stroke in young patients. METHODS: A case-control study (n = 100) comprising three participant groups: human immunodeficiency virus-positive antiretroviral therapy-naïve young strokes (n = 20), human immunodeficiency virus-negative young strokes (n = 40), and human immunodeficiency virus-positive antiretroviral therapy-naïve nonstroke controls (n = 40). von Willebrand factor and ADAMTS13 levels were measured in plasma samples collected five- to seven-days poststroke. RESULTS:Human immunodeficiency virus-positive strokeparticipants had higher von Willebrand factor levels than human immunodeficiency virus-negative strokes (173·5% vs. 135%, P = 0·032). They tended to have higher levels of von Willebrand factor than human immunodeficiency virus-positive nonstroke controls (173·5% vs. 129%, P = 0·061). Human immunodeficiency virus-positive strokeparticipants had lower levels of ADAMTS13 than human immunodeficiency virus-positive nonstroke controls (0% vs. 23·5% P = 0·018) most likely due to the effect of the acute stroke. However, in the nonstroke group, these levels were significantly reduced compared with population norms. von Willebrand factor levels in all human immunodeficiency virus-positive participants were negatively correlated with CD4 counts. CONCLUSIONS:Stroke in human immunodeficiency virus infection is associated with a prothrombotic state, characterized by elevated von Willebrand factor and low ADAMTS13 levels.
Authors: Craig Corbett; Naeem Brey; Richard D Pitcher; Suzanne O'Hagan; Tonya M Esterhuizen; Felicia C Chow; Eric H Decloedt Journal: Neurology Date: 2022-06-03 Impact factor: 11.800
Authors: David Green; Lu Tian; Philip Greenland; Kiang Liu; Melina Kibbe; Russell Tracy; Sanjiv Shah; John T Wilkins; Mark D Huffman; Yihua Liao; Donald Lloyd Jones; Mary M McDermott Journal: Clin Appl Thromb Hemost Date: 2016-06-17 Impact factor: 2.389
Authors: Amir Abdallah; Jonathan L Chang; Cumara B O'Carroll; Abdu Musubire; Felicia C Chow; Anthony L Wilson; Mark J Siedner Journal: J Stroke Cerebrovasc Dis Date: 2018-04-05 Impact factor: 2.677
Authors: Frederik Denorme; Peter Kraft; Inge Pareyn; Christiane Drechsler; Hans Deckmyn; Karen Vanhoorelbeke; Christoph Kleinschnitz; Simon F De Meyer Journal: PLoS One Date: 2017-06-07 Impact factor: 3.240
Authors: Susan M Graham; Robin M Nance; Junmei Chen; Jennie Le; Dominic W Chung; Mark M Wurfel; David L Tirschwell; Joseph R Zunt; Christina M Marra; Emily L Ho; Andrew Huffer; Felicia C Chow; Jeffrey N Martin; Alice S Ryan; Heidi M Crane; José A López; W Conrad Liles Journal: Open Forum Infect Dis Date: 2021-10-21 Impact factor: 4.423
Authors: Michał Sojka; Anna Drelich-Zbroja; Maryla Kuczyńska; Mateusz Cheda; Izabela Dąbrowska; Ewa Kopyto; Izabela Halczuk; Monika Zbroja; Weronika Cyranka; Tomasz Jargiełło Journal: Int J Environ Res Public Health Date: 2022-09-19 Impact factor: 4.614
Authors: Kieron South; Laura McCulloch; Barry W McColl; Mitchell Sv Elkind; Stuart M Allan; Craig J Smith Journal: Int J Stroke Date: 2020-07-24 Impact factor: 6.948